Mouse anti Rat TCR V Beta 10 antibody, clone G101
recognizes the T-cell receptor V beta 10 gene product.
Approximately 4.2% of unseparated LEW lymph node cells were detected by this clone. Reactivity is restricted to alpha/beta T cells, of which 6.7% labeled (Torres-Nagel et al. 1993
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by ion exchange chromatography from tissue culture supernatant
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- Carrier Free
- T cell clone expressing the TCR V beta 10 gene product.
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Fusion Partners
- Spleen cells form immunised BALB/c mice were fused with cells of the X63.Ag8.653 myeloma cell line.
- Store at +4oC or at -20oC if preferred.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- 12 months from date of despatch
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of TCR V Beta 10 antibody
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
- Flow Cytometry
- Use 10ul of the suggested working dilution to label 106 cells in 100ul.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Negative Isotype Controls Available
Product Specific References
References for TCR V Beta 10 antibody
Torres-Nagel, N.E. et al. (1993) Identification of rat Tcrb-V8.2, 8.5, and 10 gene products by monoclonal antibodies.
Immunogenetics. 37 (4): 305-8.
Hanaoka, M. et al. (2010) Immunomodulatory strategies prevent the development of autoimmune emphysema.
Respir Res. 11: 179.
Park, J.H. et al. (1996) Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
Eur J Immunol. 26: 2371-5
Matsumoto, Y. et al. (2000) Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR.
J Immunol. 164 (4): 2248-54.